0

Close
 
Upcoming Allied Market Research
2023
Tubeless Insulin Pump Market

Tubeless Insulin Pump Market: Global Opportunity Analysis and Industry Forecast, 2020-2030 Market

LS : Medical Devices & Supplies
Report Code: A12064
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Tubeless Insulin Pump Market

Request Now !

Tubeless insulin pumps are tiny, unobtrusive, and lightweight in nature and are also refereed as insulin patch pumps. These products are discrete, cost-effective, easily adhere to human body, and easy to use. As per NCBI, patients having type 1 diabetes prefer tubeless insulin pumps. Currently, these pumps make use of Nitinol Wire, spring, Step Motor, Piezoelectric crystal, Manual pumping chamber, and bladder for insulin delivery. These tubeless insulin pumps are available in myriad sizes and technologies. These products can be worn and effectively handled under clothing. With mounting cases of diabetes, especially among geriatric patients, the tubeless insulin pump market is estimated to witness significant growth over the upcoming years. According to National Diabetes Statistics, approximately 30.3 million people suffered from diabetes across the U.S. in the year 2015. Rising prevalence of diabetes will accelerate the adoption rate of tubeless insulin pump systems for better care and management of disease.

Covid-19 Scenario analysis:

There has been an increase in the demand for medical supplies to take care of infected population. Respiratory support devices such as atomizers, life-support machines, oxygen generators, and monitors are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. There is an increase in the need for medical supplies, both from healthcare professionals and civil population for precautionary measures, owing to the rise in number of COVID-19 cases worldwide. Manufacturers of these products have a chance to capitalize this increased demand for medical supplies to ensure adequate and continuous supply of personal protective equipment in the market. Therefore, COVID 19 is expected to have a significant impact on the tubeless insulin pumps market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:

Drivers:

Technological advancements

The diabetes care industry has made continuous strides. An array of insulin pump technologies with better management of hyperglycaemia and hypoglycaemia episodes and improved patient comfort has been unveiled over the past several years. Broadly, the evolution of the demand for these insulin pumps, notably tubeless pumps, has been guided by changing regulatory landscape, and evidently constant technological advancements. Particularly, advances in continuous insulin delivery systems including the automation of them has unlocked undoubtedly incredible prospects. The tubeless insulin pumps market has seen new growth trajectories from relentless efforts by medical device makers to expand the choice for patients. Apart from this, the use of tubeless insulin pumps has brought an improvement in the quality of life measures as compared to multiple-dose insulin injections. Fast evolving demand for smart insulin pumps in developed countries has opened new avenues in other regions.

Ease and convenience

A tubeless insulin pump is convenient, portable and effective in achieving better blood glucose level control, eliminating the need for daily insulin injection doses. Benefits such as less pain involved and better convenience in insulin delivery will form the major factors for higher product preference. Devices such as Omni pod is a novel tubeless insulin pump which displays blood glucose levels, schedules insulin delivery and calculates optimal insulin dosage based on the food database. Increased adoption of non-invasive transdermal insulin delivery systems has improved patient compliance for diabetes treatment. Use of microneedles and micro-emulsions improves permeation of insulin through the transdermal route. Other effective routes of insulin administration such as oral, buccal, nasal is explored as alternative non-invasive modes of delivery but none as convenient as tubeless insulin pumps.

Increase in geriatric population and diabetic patients

Increasing prevalence of diabetes due to obesity and increasing geriatric population is driving demand for tubeless insulin pump market. According to the World Health Organization, 2016, an estimated 422 million adults were suffering from diabetes globally. New technologies incorporated into tubeless insulin pump devices is leading to increasing demand for insulin pump devices worldwide. Market players are focused on developing new technologies in tubeless insulin pump devices, which can be used at home with ease and with accurate results, this in turn is expected to boost overall market growth

Regional Analysis:

North America tubeless insulin pump market will face momentous growth over upcoming years. High adoption of tubeless insulin pump and continuous government initiatives to create awareness regarding diabetes management will highly contribute to market growth. Moreover, presence of established market players in the region along with increasing approval of new devices by the U.S. FDA will highly impact North America tubeless insulin pump industry growth in upcoming years.

Indian market held significant revenue share in 2020 and is estimated to expand at significant rate over forecast period. According to the National Health Portal of India, approximately 7.2 crore people suffered from diabetes, in year 2017. Growing availability and adoption of home-based portable devices will augment the market growth. Furthermore, emerging healthcare infrastructure, rising spending capacity of the population and rising awareness about various diabetes care devices will drive Indian market growth in the foreseeable future.

Key benefits of the report:

  • This study presents the analytical depiction of the global tubeless insulin pump industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global tubeless insulin pump market share.
  • The current market is quantitatively analyzed to highlight the global Tubeless insulin pump market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the tubeless insulin pump market.
  • The report provides a detailed global Tubeless insulin pump market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Tubeless Insulin Pump Market Research Report:

  • What are the leading market players active in the tubeless insulin pump market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the tubeless insulin pump market?
  • What are the projections for the future that would help in taking further strategic steps?

 Tubeless Insulin Pump Market: Global Opportunity Analysis and Industry Forecast, 2020-2030 Report Highlights

Aspects Details
By Type
  • Insulin patch pump
  • Traditional pump
By Component
  • Pod or Patch
  • Remote
  • Accessories
By End Users
  • Hospitals
  • Pharmacies
  • E-commerce
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Spring Health Solution Ltd., Insulet Corporation, Johnson and Johnson, Medtrum Technologies Inc., Abbott Diabetes Care, Cellnovo Group SA, Medtronic Plc., Debiotech, CeQur SA, Roche Holding AG, Tandem Diabetes Care
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: TUBELESS INSULIN PUMP MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Insulin Patch Pump

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Traditional Pump

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: TUBELESS INSULIN PUMP MARKET, BY COMPONENT

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Component

    • 5.2. Pod Or Patch

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Remote

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Accessories

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: TUBELESS INSULIN PUMP MARKET, BY END USERS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End Users

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Pharmacies

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. E-commerce

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: TUBELESS INSULIN PUMP MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Component

      • 7.2.4. Market Size and Forecast, By End Users

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Tubeless Insulin Pump Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Component
        • 7.2.6.3. Market Size and Forecast, By End Users

      • 7.2.7. Canada Tubeless Insulin Pump Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Component
        • 7.2.7.3. Market Size and Forecast, By End Users

      • 7.2.8. Mexico Tubeless Insulin Pump Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Component
        • 7.2.8.3. Market Size and Forecast, By End Users

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Component

      • 7.3.4. Market Size and Forecast, By End Users

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Tubeless Insulin Pump Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Component
        • 7.3.6.3. Market Size and Forecast, By End Users

      • 7.3.7. Germany Tubeless Insulin Pump Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Component
        • 7.3.7.3. Market Size and Forecast, By End Users

      • 7.3.8. Italy Tubeless Insulin Pump Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Component
        • 7.3.8.3. Market Size and Forecast, By End Users

      • 7.3.9. Spain Tubeless Insulin Pump Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Component
        • 7.3.9.3. Market Size and Forecast, By End Users

      • 7.3.10. UK Tubeless Insulin Pump Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Component
        • 7.3.10.3. Market Size and Forecast, By End Users

      • 7.3.11. Russia Tubeless Insulin Pump Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Component
        • 7.3.11.3. Market Size and Forecast, By End Users

      • 7.3.12. Rest Of Europe Tubeless Insulin Pump Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Component
        • 7.3.12.3. Market Size and Forecast, By End Users

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Component

      • 7.4.4. Market Size and Forecast, By End Users

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Tubeless Insulin Pump Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Component
        • 7.4.6.3. Market Size and Forecast, By End Users

      • 7.4.7. Japan Tubeless Insulin Pump Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Component
        • 7.4.7.3. Market Size and Forecast, By End Users

      • 7.4.8. India Tubeless Insulin Pump Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Component
        • 7.4.8.3. Market Size and Forecast, By End Users

      • 7.4.9. South Korea Tubeless Insulin Pump Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Component
        • 7.4.9.3. Market Size and Forecast, By End Users

      • 7.4.10. Australia Tubeless Insulin Pump Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Component
        • 7.4.10.3. Market Size and Forecast, By End Users

      • 7.4.11. Thailand Tubeless Insulin Pump Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Component
        • 7.4.11.3. Market Size and Forecast, By End Users

      • 7.4.12. Malaysia Tubeless Insulin Pump Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Component
        • 7.4.12.3. Market Size and Forecast, By End Users

      • 7.4.13. Indonesia Tubeless Insulin Pump Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Component
        • 7.4.13.3. Market Size and Forecast, By End Users

      • 7.4.14. Rest of Asia Pacific Tubeless Insulin Pump Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Component
        • 7.4.14.3. Market Size and Forecast, By End Users

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Component

      • 7.5.4. Market Size and Forecast, By End Users

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Tubeless Insulin Pump Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Component
        • 7.5.6.3. Market Size and Forecast, By End Users

      • 7.5.7. South Africa Tubeless Insulin Pump Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Component
        • 7.5.7.3. Market Size and Forecast, By End Users

      • 7.5.8. Saudi Arabia Tubeless Insulin Pump Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Component
        • 7.5.8.3. Market Size and Forecast, By End Users

      • 7.5.9. UAE Tubeless Insulin Pump Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Component
        • 7.5.9.3. Market Size and Forecast, By End Users

      • 7.5.10. Argentina Tubeless Insulin Pump Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Component
        • 7.5.10.3. Market Size and Forecast, By End Users

      • 7.5.11. Rest of LAMEA Tubeless Insulin Pump Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Component
        • 7.5.11.3. Market Size and Forecast, By End Users

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Insulet Corporation

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Johnson And Johnson

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Medtrum Technologies Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Roche Holding AG

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Cellnovo Group SA

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Spring Health Solution Ltd.

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Debiotech, CeQur SA

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Abbott Diabetes Care

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Medtronic Plc.

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Tandem Diabetes Care

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL TUBELESS INSULIN PUMP MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL TUBELESS INSULIN PUMP MARKET FOR INSULIN PATCH PUMP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL TUBELESS INSULIN PUMP MARKET FOR TRADITIONAL PUMP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL TUBELESS INSULIN PUMP MARKET, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL TUBELESS INSULIN PUMP MARKET FOR POD OR PATCH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL TUBELESS INSULIN PUMP MARKET FOR REMOTE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL TUBELESS INSULIN PUMP MARKET FOR ACCESSORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL TUBELESS INSULIN PUMP MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL TUBELESS INSULIN PUMP MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL TUBELESS INSULIN PUMP MARKET FOR PHARMACIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL TUBELESS INSULIN PUMP MARKET FOR E-COMMERCE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL TUBELESS INSULIN PUMP MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA TUBELESS INSULIN PUMP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 17. U.S. TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. U.S. TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 19. U.S. TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 20. CANADA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. CANADA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 22. CANADA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE TUBELESS INSULIN PUMP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 30. FRANCE TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. FRANCE TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 32. FRANCE TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 36. ITALY TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. ITALY TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 38. ITALY TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 39. SPAIN TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. SPAIN TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 41. SPAIN TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 42. UK TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. UK TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 44. UK TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 45. RUSSIA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. RUSSIA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 47. RUSSIA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC TUBELESS INSULIN PUMP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 55. CHINA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. CHINA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 57. CHINA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 58. JAPAN TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 59. JAPAN TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 60. JAPAN TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 61. INDIA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. INDIA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 63. INDIA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 67. AUSTRALIA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. AUSTRALIA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 69. AUSTRALIA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 70. THAILAND TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. THAILAND TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 72. THAILAND TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 73. MALAYSIA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 74. MALAYSIA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 75. MALAYSIA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 76. INDONESIA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 77. INDONESIA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 78. INDONESIA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 79. REST OF ASIA PACIFIC TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 82. LAMEA TUBELESS INSULIN PUMP, BY REGION, 2022-2032 ($MILLION)
  • TABLE 83. LAMEA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. LAMEA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 85. LAMEA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 86. BRAZIL TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 87. BRAZIL TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 88. BRAZIL TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH AFRICA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH AFRICA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH AFRICA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 92. SAUDI ARABIA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 93. SAUDI ARABIA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 94. SAUDI ARABIA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 95. UAE TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 96. UAE TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 97. UAE TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 98. ARGENTINA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 99. ARGENTINA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 100. ARGENTINA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 101. REST OF LAMEA TUBELESS INSULIN PUMP, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 102. REST OF LAMEA TUBELESS INSULIN PUMP, BY COMPONENT, 2022-2032 ($MILLION)
  • TABLE 103. REST OF LAMEA TUBELESS INSULIN PUMP, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 104. INSULET CORPORATION: KEY EXECUTIVES
  • TABLE 105. INSULET CORPORATION: COMPANY SNAPSHOT
  • TABLE 106. INSULET CORPORATION: OPERATING SEGMENTS
  • TABLE 107. INSULET CORPORATION: PRODUCT PORTFOLIO
  • TABLE 108. INSULET CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 109. JOHNSON AND JOHNSON: KEY EXECUTIVES
  • TABLE 110. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
  • TABLE 111. JOHNSON AND JOHNSON: OPERATING SEGMENTS
  • TABLE 112. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
  • TABLE 113. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. MEDTRUM TECHNOLOGIES INC.: KEY EXECUTIVES
  • TABLE 115. MEDTRUM TECHNOLOGIES INC.: COMPANY SNAPSHOT
  • TABLE 116. MEDTRUM TECHNOLOGIES INC.: OPERATING SEGMENTS
  • TABLE 117. MEDTRUM TECHNOLOGIES INC.: PRODUCT PORTFOLIO
  • TABLE 118. MEDTRUM TECHNOLOGIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. ROCHE HOLDING AG: KEY EXECUTIVES
  • TABLE 120. ROCHE HOLDING AG: COMPANY SNAPSHOT
  • TABLE 121. ROCHE HOLDING AG: OPERATING SEGMENTS
  • TABLE 122. ROCHE HOLDING AG: PRODUCT PORTFOLIO
  • TABLE 123. ROCHE HOLDING AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. CELLNOVO GROUP SA: KEY EXECUTIVES
  • TABLE 125. CELLNOVO GROUP SA: COMPANY SNAPSHOT
  • TABLE 126. CELLNOVO GROUP SA: OPERATING SEGMENTS
  • TABLE 127. CELLNOVO GROUP SA: PRODUCT PORTFOLIO
  • TABLE 128. CELLNOVO GROUP SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. SPRING HEALTH SOLUTION LTD.: KEY EXECUTIVES
  • TABLE 130. SPRING HEALTH SOLUTION LTD.: COMPANY SNAPSHOT
  • TABLE 131. SPRING HEALTH SOLUTION LTD.: OPERATING SEGMENTS
  • TABLE 132. SPRING HEALTH SOLUTION LTD.: PRODUCT PORTFOLIO
  • TABLE 133. SPRING HEALTH SOLUTION LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. DEBIOTECH, CEQUR SA: KEY EXECUTIVES
  • TABLE 135. DEBIOTECH, CEQUR SA: COMPANY SNAPSHOT
  • TABLE 136. DEBIOTECH, CEQUR SA: OPERATING SEGMENTS
  • TABLE 137. DEBIOTECH, CEQUR SA: PRODUCT PORTFOLIO
  • TABLE 138. DEBIOTECH, CEQUR SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. ABBOTT DIABETES CARE: KEY EXECUTIVES
  • TABLE 140. ABBOTT DIABETES CARE: COMPANY SNAPSHOT
  • TABLE 141. ABBOTT DIABETES CARE: OPERATING SEGMENTS
  • TABLE 142. ABBOTT DIABETES CARE: PRODUCT PORTFOLIO
  • TABLE 143. ABBOTT DIABETES CARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. MEDTRONIC PLC.: KEY EXECUTIVES
  • TABLE 145. MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 146. MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 147. MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 148. MEDTRONIC PLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. TANDEM DIABETES CARE: KEY EXECUTIVES
  • TABLE 150. TANDEM DIABETES CARE: COMPANY SNAPSHOT
  • TABLE 151. TANDEM DIABETES CARE: OPERATING SEGMENTS
  • TABLE 152. TANDEM DIABETES CARE: PRODUCT PORTFOLIO
  • TABLE 153. TANDEM DIABETES CARE: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL TUBELESS INSULIN PUMP MARKET SEGMENTATION
  • FIGURE 2. GLOBAL TUBELESS INSULIN PUMP MARKET
  • FIGURE 3. SEGMENTATION TUBELESS INSULIN PUMP MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN TUBELESS INSULIN PUMP MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALTUBELESS INSULIN PUMP MARKET
  • FIGURE 11. TUBELESS INSULIN PUMP MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. TUBELESS INSULIN PUMP MARKET FOR INSULIN PATCH PUMP, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. TUBELESS INSULIN PUMP MARKET FOR TRADITIONAL PUMP, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. TUBELESS INSULIN PUMP MARKET SEGMENTATION, BY BY COMPONENT
  • FIGURE 15. TUBELESS INSULIN PUMP MARKET FOR POD OR PATCH, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. TUBELESS INSULIN PUMP MARKET FOR REMOTE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. TUBELESS INSULIN PUMP MARKET FOR ACCESSORIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. TUBELESS INSULIN PUMP MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 19. TUBELESS INSULIN PUMP MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. TUBELESS INSULIN PUMP MARKET FOR PHARMACIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. TUBELESS INSULIN PUMP MARKET FOR E-COMMERCE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 26. COMPETITIVE DASHBOARD
  • FIGURE 27. COMPETITIVE HEATMAP: TUBELESS INSULIN PUMP MARKET
  • FIGURE 28. Top player positioning, 2022
  • FIGURE 29. INSULET CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 30. INSULET CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 31. INSULET CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 32. JOHNSON AND JOHNSON: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. MEDTRUM TECHNOLOGIES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. MEDTRUM TECHNOLOGIES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. MEDTRUM TECHNOLOGIES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. ROCHE HOLDING AG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. ROCHE HOLDING AG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. ROCHE HOLDING AG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. CELLNOVO GROUP SA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. CELLNOVO GROUP SA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. CELLNOVO GROUP SA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. SPRING HEALTH SOLUTION LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. SPRING HEALTH SOLUTION LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. SPRING HEALTH SOLUTION LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. DEBIOTECH, CEQUR SA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. DEBIOTECH, CEQUR SA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. DEBIOTECH, CEQUR SA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. ABBOTT DIABETES CARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. ABBOTT DIABETES CARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. ABBOTT DIABETES CARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. MEDTRONIC PLC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. MEDTRONIC PLC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. MEDTRONIC PLC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. TANDEM DIABETES CARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. TANDEM DIABETES CARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. TANDEM DIABETES CARE: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Tubeless Insulin Pump Market

Start reading.
This Report and over 68,418+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers